Low COVID-19 vaccination rates among Medicaid beneficiaries cause for concern: senators
By
Kimberly Bonvissuto
Mar 29, 2022
Concern over lagging vaccination rates among Medicaid beneficiaries has prompted two Democratic leaders to request a study from the Government Accountability Office on potential barriers to vaccination.
Risk for myocarditis low after third dose of BNT162b2 vaccine
Mar 24, 2022
The incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week to two weeks after third dose..
Fourth mRNA COVID-19 vaccine immunogenic, safe
Mar 24, 2022
Vaccine efficacy 30% for BNT162b2(Pfizer) and 11 percent for mRNA-1273 (Moderna) against any SARS-CoV-2 infection.
When COVID case counts are low, relax but prepare for future outbreaks: speaker
By
Kimberly Bonvissuto
Mar 24, 2022
It’s OK to relax a little and take off that mask when community COVID-19 transmission rates are low. But an epidemiologist says that that’s also the time to prepare.
Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
No myocarditis recurrence after SARS-CoV-2 vaccination
Mar 22, 2022
No cases of myocarditis were seen after vaccination in small study with 55 patients with a history of myocarditis who were vaccinated.
Risk for shoulder conditions small after vaccination in deltoid muscle
Mar 21, 2022
The incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years).
COVID-19 vaccines not tied to immune-mediated neurological events
Mar 21, 2022
But increased risks for Bell palsy, encephalomyelitis and Guillain-Barré syndrome were observed following SARS-CoV-2 infection.
Moderna asks FDA to approve second booster for all adults
Mar 18, 2022
The Moderna request covers all adults to give federal health officials the freedom to determine who should get a second booster.
Risk for blood clots after COVID-19 vaccination explored
Mar 11, 2022
Two studies show an increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S.